Rheumnow Podcast

Featuring: Dr. Jeffrey Curtis: AI applied to Rheumatoid Arthritis Care: Practically (Not) Perfect Dr. Una Makris: Key Considerations When Managing Older Adults with RA Dr. Bryant England: Who will manage multimorbidity in RA

A JAKi in GCA- Phase 3 Results Through 2 Years Sponsored by AbbVie Medical Affairs + Health Impact

A focused discussion on updates in spondyloarthritis, including emerging data, treatment strategies, and real-world care considerations. Hear expert perspectives and practical takeaways shaping SpA management today.

A focused conversation on the latest in CAR-T from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what’s shaping CAR-T practice right now.

A focused conversation on the latest in psoriatic arthritis care — from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what’s shaping PsA practice right now.

A focused conversation on the latest in psoriatic arthritis care - from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what's shaping PsA practice right now.

Stay plugged into the conversations, discoveries, and breakthroughs moving rheumatology forward. Real updates. Real context. For clinicians who never stop learning.

Dr. Jack Cush recaps ACR2025 with suggestions on how to best learn ACR25 content from RheumNow.com and our Videos and podcasts.

NEPTUNUS: Ianalumab in Sjogren's Pulmonary hypertension in Sarcoidosis

Restoring B Cell Compartments with CAR T: Molecular Data is Here CAR-T: The Future

Revised Classification Criteria in axSpA https://www.youtube.com/watch?v=voFJrQo1ANU NSAID Addition Helps the Spine but not the Hips https://www.youtube.com/watch?v=wTKMC1MTwpE Biomarker Discovery in axSpA https://www.youtube.com/watch?v=X8Sc_3oBSVA Sexual Function in axSpA https://www.youtube.com/watch?v=r4_Nsh7e_oo Coping Strategies in axSpA https://www.youtube.com/watch?v=z9KdNuOu4nI "ROC-SpA Study" https://www.youtube.com/watch?v=kIEN39XRsSM Why do patients stay in clinical trials? https://www.youtube.com/watch?v=pVIBoN0jO2o What to do after first TNR failure in axSpA? https://www.youtube.com/watch?v=PVSyq_Y5-PE

ILD in Patients with Connective Tissue Disease Fiber and Methotrexate RA ILD Prediction: simple as a dipstick? "Leftover Pain in Inflammatory Arthritis"

From Pain to Wellness in PsA Secukinumab vs Ustekinumab in PsA Izokibep: still enthused about enthesitis? Using Digital Apps to Modify Pain in axSpA

"ROC-SpA Study" Secukinumab vs Ustekinumab in PsA RA ILD Prediction: simple as a dipstick? Sjogren's Disease: PROs as a Filter for Precision Medicine Why do patients stay in clinical trials? Using Digital Apps to Modify Pain in axSpA IgG4: Rare but Treatable!

From Pain to Wellness in PsA IL-2 Therapy in SLE? Maybe Sexual Function in axSpA "Fact or Fiction: Trinetics Research at ACR" CD1/BCMA Dual Targeting: One too many targets in SLE Hydroxychloroquine Blood Levels The Great Debate: AI in Rheumatology Coping Strategies in axSpA "What to do After First TNR Failure in axSpA"

Join panelists Drs. Brian Jaros, Akhil Sood and Michael Putman as they recap highlights from Day 4, the final day of the 2025 ACR Convergence meeting in Chicago.

Join RheumNow Faculty Drs. Shelia Reyes, Mike Putman, Bella Mehta, and Jack Cush as they discuss highlights and key takeaways from the Day 3 Recap, at the 2025 ACR Convergence meeting in Chicago.

Screen RA ILD Properly Rheumatoid Arthritis Highlights Predicting Rheumatoid Arthritis GDF-15: How Depression is Related to Lung Disease in RA

"Leftover Pain in Inflammatory Arthritis" Another Specialized Biomarker in PsA Secrets and Pearls in Rheumatology What's the latest in PsA?

GDF-15: How Depression is Related to Lung Disease in RA What Can we do About Chronic Pain? What's the latest in PsA? What to do after first TNR failure in axSpA?

Secrets and Pearls in Rheumatology Addressing Lupus Nephritis Timely Fake Rheum Diagnostic Dilemmas Rheumatoid Arthritis Highlights Restoring B Cell Compartments with CAR T: Molecular Data is Here Predicting Rheumatoid Arthritis h What Causes Infection in Vasculitis? Is it All About the Weight Loss? Izokibep: still enthused about enthesitis? T Cell Engagers: Are we engaged? Fiber and Methotrexate

Spondyloarthritis: The CLASSIC Study "Leftover Pain in Inflammatory Arthritis" NeuroImmune Modulation in RA: Results of the RESET RA Trial Change it or Keep it? TNF in Axial SpA Perspectives on CAR T Therapy Addressing Lupus Nephritis Early Addressing Lupus Nephritis Aggressively CAR-T: The Future Biomarker Discovery in axSpA Another Specialized Biomarker in PsA Revised Classification Criteria in axSpA

Catching AxSpA Early: Closing the Diagnostic Gap Early Peripheral SpA: Is it okay to stop treatment sometimes? Difficult to Manage axSpA Tofacitinib in AxSpA in Developing Countries Late-Breaking Trials in axSpA and PsA Durability and Safety of Bimekizumab Biologics Improve Sexual Function in axSpA Multidimensional Pain inventory in Axial SpA Spondyloarthritis: The CLASSIC Study Change it or Keep it? TNF in Axial SpA "Leftover Pain in Inflammatory Arthritis"

B Cell Depletion: Check the Lymph Node "Next Generation T-Cell Engager: The Future" Off the Shelf: CAR-T Combining CAR-T with CAR-Treg All in One CAR-T Therapy: Where is it Heading? Safety of CAR-T New Paradigms in RA Treatment Perspectives on CAR T Therapy

Wired for Success: Vagal Nerve Therapy in RA RA: Does upfront TNFi save heartache? New Paradigms in RA Treatment

SLGT-2 and GLP-1 in RA: More than Weight Loss ACR2025 Day 1 RECAP

Cellular Biomarkers of Rheumatoid Arthritis Day 2 Recap: ACR Convergence 2025 Highlights

STOP RA Cellular & Serologic Predictors Rheumatoid Arthritis: Inject the Steroids Is Low Disease Activity Low Enough?

Catching PsA before it Starts Day 2 Recap: ACR Convergence 2025 Highlights

PsA and Brain Fog GLP-1 Receptor Agonists in PsA: Mortality and MACE PsA Predictors When the Back Hurts: uncovering BASDAI drivers in PsA The Upper Hand in PsA? Not the Dominant One

Diagnostic Delays in PsA: A Radiographic Perspective Late-Breaking Trials in axSpA and PsA New Approaches to Therapy in PsA

Psoriatic Arthritis Imaging Specialized Biomarkers in PsA PsA: Impact of Sex GLP-1 and SGLT-2: Treatments Too Good to Ignore?

Safety of NSAIDs in Inflammatory Bowel Disease Screen RA ILD Properly Biologics Improve Sexual Function in axSpA Catching PsA before it Starts Multidimensional Pain inventory in Axial SpA RA: Does upfront TNFi save heartache? Novel Insights into Sjogren's Disease New Paradigms in RA Treatment Biomarkers in Still's and Macrophage Activation Syndrome "The Power of Gamma Delta T Cell for Autoimmunity" The Heartbreak of Sarcoidosis

NSAID Addition Helps the Spine but not the Hips Durability and Safety of Bimekizumab Progressive BiTE in SLE 2 Hydroxychloroquine Reduces Autoantibody Levels When the Back Hurts: uncovering BASDAI drivers in PsA The Upper Hand in PsA? Not the Dominant One Airway Disease in GPA Wired for Success: Vagal Nerve Therapy in RA GLP-1 in Knee Osteoarthritis Disparities in Physical Function in SLE

Putting Steroid Tapering into Practice in SLE Tocilizumab Beats Methotrexate in GCA GLP-1 Receptor Agonists in PsA: Mortality and MACE Safety of CAR-T ILD in Patients with Connective Tissue Disease SLGT-2 and GLP-1 in RA: More than Weight Loss PsA Predictors Ianalumab: Breakthrough Therapy in Sjogren's

Off the Shelf: CAR-T Combining CAR-T with CAR-Treg All in One Tapering in SELECT GCA: Steroids are the Problem Diagnostic Delays in PsA: A Radiographic Perspective Late-Breaking Trials in axSpA and PsA New Approaches to Therapy in PsA PRED-SAFE: Chronic Prednisone Use PsA and Brain Fog CAR-T Therapy: Where is it Heading?

Join RheumNow Faculty Drs. David Liew, Antoni Chan, Mrinalini Dey, and Jack Cush as they discuss highlights and key takeaways from the Day 2 Recap on Monday, October 27th, at the 2025 ACR Convergence meeting in Chicago.

A Nose for Vasculitis: ENT Manifestations in ANCA-Associated Disease Tofacitinib in AxSpA in Developing Countries Specialized Biomarkers in PsA B Cell Depletion: Check the Lymph Node GLP-1 and SGLT-2: Treatments Too Good to Ignore? Nerandomilast for ILD PsA: Impact of Sex Cellular Biomarkers of Rheumatoid Arthritis Using AI and LLMs in Qualitative Data Belimumab Before or After Immunosuppressant Do Patients with Rheumatic Diseases 'Weather' the Storm? AI in Fellow Recruitment: A New Dawn in Medical Education?

AI Scribes Found their Favorite Doctors Hospitalization in Stills: Is it "Still" an Infection? Upadacitinib is a Double Edged Vascular Sword in GCA Rheumatoid Arthritis: Inject the Steroids Catching AxSpA Early: Closing the Diagnostic Gap Is Low Disease Activity Low Enough? Early Peripheral SpA: Is it okay to stop treatment sometimes? Difficult to Manage axSpA

STOP RA Cellular & Serologic Predictors Is AI Smarter than a Doctor? Lung Disease in ANCA-associated Vasculitis Older Adults Underrepresented in RCTs Next Generation T-Cell Engager: The Future Lupus in Focus: 2025 ACR Treatment Guidelines for SLE Psoriatic Arthritis Imaging

Big takeaways, standout moments, and what set the tone for this year’s conference. We break down the key insights, early trends, and conversations shaping Day 1.

Dr. Jack Cush reviews the news and info reports the day before ACR 2025.

DERM on RheumNow PODCAST (October 2025) Skin important Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com. SHOW NOTES 1. Skin Biopsies to Predict Scleroderma Outcomes? 2. Fibromyalgia in PsO & PsA is linked to greater treatment complexity and shorter biologic therapy survival. Retro matched 1:4 cohort study 61K PsO& 244K controls. FM prevalence 3.3% (OR 1.45). In PsA w/ FM, req more biologics w/ decr biologic survival (6 vs 10yrs) w/ incr switching (HR 1.82) https://buff.ly/TCc6Kc8 3. Guselkumab FDA Approved for Pediatric Psoriasis and Psoriatic Arthritis https://rheumnow.com/news/guselkumab-fda-approved-pediatric-psoriasis-and-psoriatic-arthritis 4. Sonelokimab (SLK) is a nanobody that inhibits IL-17 A&F. Phase 2 ARGO trial 207 active PsA pts Rx w/ SLK 120-mg or 60-mg q4wks or PBO or adalimumab. ACR50 at wk 12 was 60-mg WI=46%; 120-mg WI=46%; PBO 20%. PASI90: 60mg 77% vs 120mg 59% vs PBO 15% https://t.co/ra0NqvUEru https://t.co/FXT6kkXUzH 5. Turkish study of 799 psoriasis pts - 30% had concurrent onset PsO & PsA & in 70% there was a long transition time (~13 yrs) from PsO-to-PsA. Factors assoc w/ prolonged interval included Depression, fatigue, scalp PsO(OR 7), nail PsO (3.2), +Fhx & enthesitis ever (OR 2) https://t.co/wqtSbeQ2vz 6. Mediterranean Diet Efficacy in Psoriasis 7. Gender Complexities in Psoriatic Arthritis Treatment Outcomes

Dr. Jack Cush reviews the news and journal reports, discusses pediatric reports, pregnancy data, diet and nutrition and more.

Dr. Jack Cush reviews the news, journal reports and important associations in rheumatology from the past week on RheumNow.com.

Our final webinar in this month's Rheum to Breathe: ILD campaign brings together ILD experts to discuss best practices in diagnosis, screening, and monitoring, covering: tools, labs, and imaging; timing and frequency of screening; ILD screening in RA; and, referral strategies. Panelists: Shane Shapera, MD Elana Bernstein, MD Bryant England, MD Moderator: Jack Cush, MD

Experts Dr. Jeffrey Curtis and Dr. Kevin Winthrop discuss best practices for shared decision-making, how to talk with patients about the risks of poorly controlled RA, and ways to use a new tool for visualizing the long-term safety of a JAKi.

QD clinics on ILD - lessons from the Clinic; brought to during the "Rheum to Breathe" ILD campaign ILD QD Clinic #4 ILD QD Clinics - Worsening Breathlessness in SSc ILD: The Pressure Is On ILD QD clinics on ILD #1 - Be Careful What you Look For